Floatz logo

Cyclophosphamide

Adult Solid Neoplasm

Jonsson Comprehensive Cancer CenterSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Adult Solid Neoplasm cohort.

Asset / SponsorPhaseRating
Veliparib
National Cancer Institute (NCI)
Phase 1/2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Roswell Park Cancer Institute
Phase 1/2BB
Vinorelbine
National Cancer Institute (NCI)
Phase 1/2BB
azd6244
National Cancer Institute (NCI)
Phase 2BB
Cediranib
National Cancer Institute (NCI)
Phase 1/2B

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →